Showing 1 - 10 of 1,099
conclude that large foreign acquisitions from India have not created shareholder value. The causes of this under-performance …
Persistent link: https://www.econbiz.de/10013144985
This study of the Indian Pharmaceutical Industry (IPI) attempts to identify existing and proposed business models for the choice of strategic options for the success of the Indian pharmaceutical industry in the New Patent Regime. As part of the study, a number of company and industry reports,...
Persistent link: https://www.econbiz.de/10013066289
In last few years, rural markets have acquired significant importance in India, as the overall growth of the economy has resulted into sizeable increase in the purchasing power of the rural population. On account of the green revolution in India, the rural areas are consuming a large quantity of...
Persistent link: https://www.econbiz.de/10012866528
This paper further develops the stock return method proposed by Cho and McKelvey (1996). It is claimed that the method may detect industry substructure in an objective and effective way. Although they are statistically significantly different while avoiding any artifactual statistical results...
Persistent link: https://www.econbiz.de/10014053089
The paper examines the impact of financial performance of large cap and mid cap Indian Pharmaceutical companies … performance from 2015 to 2017. Financial performance was found to have different effects on companies. Earnings per share had …
Persistent link: https://www.econbiz.de/10013229849
The paper evaluates the impact of capital structure on profitability and market price of large cap and mid cap Indian pharmaceutical companies. The pharmaceutical companies listed in NSE and NSE midcap index were selected for the study. The secondary data was considered from 2013 to 2017. The...
Persistent link: https://www.econbiz.de/10013229896
The global pharmaceutical industry is in an era of greater uncertainty because of looming patent expiries of established drugs having a direct impact on their sales and profitability. Further discovering new drugs in-house is a risky, time consuming and expensive proposition. This has forced...
Persistent link: https://www.econbiz.de/10012994958
reactions, extended to multinational production. India represents an emerging country whose recent performance in terms of …
Persistent link: https://www.econbiz.de/10014202975
superior performance in the international markets. Enhancing the organizational commitment towards exporting is one such step … the performance of exporting firms from the angle of organizational commitment for exporting in use by them. The study …
Persistent link: https://www.econbiz.de/10014138081
The rising prominence of emerging market multinationals has become a salient aspect of the global economy. Among these new emerging multinationals, the Indian Pharmaceutical Companies (IPCs) have drawn the attention of the academia for their catch-up internationalization strategies and rapid...
Persistent link: https://www.econbiz.de/10014149145